(S)-1-(BOC)AZEPANE-2-CARBOXYLIC ACID, 95.0%, 500mg

2-(3,3-Difluoropyrrolidin-1-yl)ethan-1-ol, 98%, 250mg

4-[(4-methylpiperidin-1-yl)sulfonyl]benzoic acid, 95.0%, 2.5g

2,5-dioxopyrrolidin-1-yl 2-(cyclooct-2-ynyloxy)acetate, 10mg

5-CYCLOPROPYL-1,2,3-THIADIAZOLE-4-CARBOXYLIC ACID, 95.0%, 5g

4-Ethyl-4-methoxy-piperidine;hydrochloride, 95%, 10g

4-(4-Bromo-1H-pyrazol-1-yl)benzaldehyde, 95.0%, 5g

2-Chlorophenol , ≥98%, for synthesis, 1 L, glass packaging

3,3-Difluoropropan-1-amine hydrochloride, 98%, 10g

tert-Butyl (2-(prop-2-yn-1-yloxy)ethyl)carbamate, 95%, 25g

N-methyl-2-(4-methylpiperidin-1-yl)ethanamine, 95.0%, 1g

2,3,4,10b-Tetrahydro-1H-pyrazino[1,2-b]isoindol-6-one, 95+%, 1g

2-Amino-6-chloroimidazo[1,2-b]pyridazine, 95.0%, 25g